These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9544684

  • 1. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL.
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [Abstract] [Full Text] [Related]

  • 4. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X.
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 6. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN, Aprile C, Capri G, Viganò L, Munzone E, Gianni L, Pepys MB, Merlini G.
    Eur J Nucl Med; 1998 Jul 23; 25(7):701-8. PubMed ID: 9662591
    [Abstract] [Full Text] [Related]

  • 7. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.
    Hawkins PN, Wootton R, Pepys MB.
    J Clin Invest; 1990 Dec 23; 86(6):1862-9. PubMed ID: 2254450
    [Abstract] [Full Text] [Related]

  • 8. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN.
    Lancet; 2001 Jul 07; 358(9275):24-9. PubMed ID: 11454373
    [Abstract] [Full Text] [Related]

  • 9. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB.
    J Exp Med; 1988 Mar 01; 167(3):903-13. PubMed ID: 3351437
    [Abstract] [Full Text] [Related]

  • 10. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 01; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 11. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X.
    QJM; 1997 Jan 01; 90(1):45-50. PubMed ID: 9093588
    [Abstract] [Full Text] [Related]

  • 12. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM, Deveaux M, Duneton O, Foissac-Gegoux P, Dumont A, Duquesnoy B, Marchandise X.
    Nephrologie; 1995 Jan 01; 16(6):419-25. PubMed ID: 8524449
    [Abstract] [Full Text] [Related]

  • 13. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
    Shah PL, Gillmore JD, Copley SJ, Collins JV, Wells AU, du Bois RM, Hawkins PN, Nicholson AG.
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun 01; 19(2):134-42. PubMed ID: 12102609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnosis and monitoring of amyloidosis.
    Hawkins PN.
    Baillieres Clin Rheumatol; 1994 Aug 01; 8(3):635-59. PubMed ID: 7954867
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J, Caillat-Vigneron N, Ureña P, Gagné ER, Bererhi L, Moretti JL, Bardin T, Drüeke TB.
    Nephrol Dial Transplant; 1995 Aug 01; 10(2):223-9. PubMed ID: 7753457
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB, Madhoo S, Pepys MB, Hawkins PN.
    Gastroenterology; 1997 Apr 01; 112(4):1362-5. PubMed ID: 9098022
    [Abstract] [Full Text] [Related]

  • 19. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 01; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis].
    Maulin L, Hachulla E, Facon T, Deveaux M, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Marchandise W.
    Rev Med Interne; 1993 Jun 01; 14(10):962. PubMed ID: 8009058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.